Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedJul 02, 2026
DataAggregated Company Financials
Companies14
  • 7D2.4%
  • 3M3.1%
  • 1Y-9.6%
  • YTD-6.7%

The Healthcare industry is up 2.7% in the last week, with Fisher & Paykel Healthcare up 2.8%. However, the industry is down 8.6% over the past year. Earnings are forecast to grow by 21% annually.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Jul 2026NZ$32.9bNZ$20.2bNZ$829.3m16.5x39.7x1.6x
Sat, 30 May 2026NZ$31.7bNZ$20.0bNZ$825.7m17.5x38.4x1.6x
Mon, 27 Apr 2026NZ$31.2bNZ$20.0bNZ$452.0m18.1x69.1x1.6x
Wed, 25 Mar 2026NZ$31.3bNZ$19.7bNZ$447.2m18.1x70.1x1.6x
Fri, 20 Feb 2026NZ$33.1bNZ$18.6bNZ$539.1m20.5x61.4x1.8x
Sun, 18 Jan 2026NZ$35.8bNZ$18.3bNZ$535.0m21.2x66.9x2x
Tue, 16 Dec 2025NZ$35.3bNZ$18.2bNZ$532.1m21.6x66.4x1.9x
Thu, 13 Nov 2025NZ$35.6bNZ$18.0bNZ$579.3m20.1x61.5x2x
Sat, 11 Oct 2025NZ$34.3bNZ$17.8bNZ$575.5m19.5x59.7x1.9x
Mon, 08 Sep 2025NZ$34.9bNZ$17.5bNZ$569.7m18.3x61.2x2x
Wed, 06 Aug 2025NZ$36.4bNZ$17.6bNZ$571.9m18.9x63.6x2.1x
Fri, 04 Jul 2025NZ$35.5bNZ$17.5bNZ$568.7m16.7x62.5x2x
Sun, 01 Jun 2025NZ$34.7bNZ$17.4bNZ$567.9m15x61.1x2x
Tue, 29 Apr 2025NZ$33.7bNZ$17.2bNZ$653.2m15.3x51.6x2x
Thu, 27 Mar 2025NZ$32.9bNZ$17.5bNZ$659.0m17.5x49.9x1.9x
Sat, 22 Feb 2025NZ$35.2bNZ$17.6bNZ$706.8m16.7x49.9x2x
Mon, 20 Jan 2025NZ$37.2bNZ$18.3bNZ$735.3m14.2x50.6x2x
Wed, 18 Dec 2024NZ$36.6bNZ$18.2bNZ$727.4m13.2x50.3x2x
Fri, 15 Nov 2024NZ$37.7bNZ$18.2bNZ$967.8m17.4x39x2.1x
Sun, 13 Oct 2024NZ$37.8bNZ$18.3bNZ$968.0m19.9x39.1x2.1x
Tue, 10 Sep 2024NZ$37.1bNZ$18.0bNZ$962.5m20.8x38.5x2.1x
Thu, 08 Aug 2024NZ$34.3bNZ$17.5bNZ$972.5m19x35.3x2x
Sat, 06 Jul 2024NZ$29.8bNZ$17.6bNZ$974.9m16.4x30.5x1.7x
Mon, 03 Jun 2024NZ$30.0bNZ$17.3bNZ$1.2b12.9x24.9x1.7x
Wed, 01 May 2024NZ$30.6bNZ$17.4bNZ$1.3b24x23.7x1.8x
Fri, 29 Mar 2024NZ$29.2bNZ$17.3bNZ$1.3b23.6x22.7x1.7x
Sun, 25 Feb 2024NZ$28.7bNZ$16.9bNZ$1.1b18.2x25.4x1.7x
Tue, 23 Jan 2024NZ$28.7bNZ$16.7bNZ$1.1b22.8x25.4x1.7x
Thu, 21 Dec 2023NZ$28.9bNZ$16.7bNZ$1.1b23.4x25.6x1.7x
Sat, 18 Nov 2023NZ$28.3bNZ$16.5bNZ$1.1b27x25.5x1.7x
Mon, 16 Oct 2023NZ$27.3bNZ$16.3bNZ$1.1b31x24.7x1.7x
Wed, 13 Sep 2023NZ$28.1bNZ$16.6bNZ$1.1b29x25.3x1.7x
Fri, 11 Aug 2023NZ$29.3bNZ$15.8bNZ$1.1b28.9x27.3x1.9x
Sun, 09 Jul 2023NZ$30.7bNZ$15.7bNZ$1.1b29.7x28.6x2x
Price to Earnings Ratio

28.6x


Total Market Cap: NZ$30.7bTotal Earnings: NZ$1.1bTotal Revenue: NZ$15.7bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 44.7x202420252026
Current Industry PE
  • Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 39.9x which is lower than its 3-year average PE of 44.7x.
  • The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.2% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market1.14%
Healthcare2.42%
Medical Equipment2.79%
Healthcare Services1.81%
Biotech0%0
Pharma-1.71%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.5x.
    • Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FPH Fisher & Paykel HealthcareNZ$38.552.8%
+NZ$616.7m		2.8%PE48.3x
EBO EBOS GroupNZ$21.064.7%
+NZ$194.5m		-46.5%PE15.6x
SUM Summerset Group HoldingsNZ$8.832.7%
+NZ$56.0m		-22.9%PE8.3x
BLT BLIS TechnologiesNZ$0.01713.3%
+NZ$2.6m		-22.7%PE31.4x
TAH Third Age Health ServicesNZ$4.674.2%
+NZ$1.9m		41.1%PE16.5x

Latest News

TRU
NZ$0.018
TruScreen Group
7D
-5.3%
1Y
-10.0%
OCA
NZ$0.75
Oceania Healthcare
7D
-1.3%
1Y
8.7%
Narrative Update • Jun 26

OCA: Revised Assumptions Will Temper Expectations While Supporting Steady Future Earnings

Analysts have revised their fair value estimate for Oceania Healthcare from about NZ$0.84 to around NZ$0.72. This reflects updates to the discount rate, revenue growth, profit margin and future P/E assumptions used in their valuation work.
EBO
NZ$21.06
EBOS Group
7D
4.7%
1Y
-46.5%
Narrative Update • Jun 24

EBO: Slightly Higher Discount Rate Will Support Future Capital Efficiency Reassessment

Analysts have reduced their NZ$ fair value estimate for EBOS Group from about NZ$31.32 to NZ$30.13, reflecting minor changes to the discount rate, long-term revenue growth, profit margin assumptions and a slightly lower future P/E in their valuation models. What's in the News No recent company specific news items for EBOS Group were provided in the available sources.
FPH
NZ$38.55
Fisher & Paykel Healthcare
7D
2.8%
1Y
2.8%
Narrative Update • Jun 24

FPH: Stable Dividend And Earnings Outlook Will Support Measured Future Repricing

Analysts have nudged their price target for Fisher & Paykel Healthcare slightly higher to NZ$39.75, reflecting small adjustments to fair value estimates, discount rate, revenue growth, profit margin and expected future P/E assumptions. What's in the News for Fisher & Paykel Healthcare Fisher & Paykel Healthcare declared a dividend of NZ$0.38823529 per share for the six months ended March 31, 2026.
RYM
NZ$2.22
Ryman Healthcare
7D
-3.1%
1Y
-2.6%
Narrative Update • Jun 14

RYM: Capital Management And Governance Turnaround Will Support Future Upside

Analysts have kept their NZ$ fair value estimate for Ryman Healthcare unchanged, pointing to only very small adjustments in the discount rate, revenue growth outlook, profit margin assumptions and future P/E that did not materially shift their overall price target narrative. What's in the News Ryman Healthcare completed a six year fixed rate secured unsubordinated bond offer, allocating NZ$150 million after taking up oversubscriptions beyond the initial NZ$100 million target.
AFT
NZ$3.66
AFT Pharmaceuticals
7D
-2.4%
1Y
26.2%
RAD
NZ$0.38
Radius Residential Care
7D
-3.8%
1Y
13.6%
TAH
NZ$4.67
Third Age Health Services
7D
4.2%
1Y
41.1%
Analysis Article • Jun 05

Third Age Health Services' (NZSE:TAH) Earnings Offer More Than Meets The Eye

Shareholders appeared to be happy with Third Age Health Services Limited's ( NZSE:TAH ) solid earnings report last...
PHL
NZ$0.59
Promisia Healthcare
7D
-4.8%
1Y
47.5%
Analysis Article • Jun 04

We Think That There Are Issues Underlying Promisia Healthcare's (NZSE:PHL) Earnings

Promisia Healthcare Limited's ( NZSE:PHL ) stock was strong after they recently reported robust earnings. However, we...
BLT
NZ$0.017
BLIS Technologies
7D
13.3%
1Y
-22.7%
SUM
NZ$8.83
Summerset Group Holdings
7D
2.7%
1Y
-22.9%
RUA
NZ$0.028
Rua Bioscience
7D
-3.4%
1Y
-3.4%